GGrantIndex
Sort

64,565 grants matching drug discovery

Design and Study of New Nicotinic Analogs for Use in Depression

$819,419
Alan P. Kozikowski · University Of Illinois At Chicago · U19 · FY2013 · MH

Drug Target Discovery, Validation, and Prioritization for Schistosomiasis

$819,288
James J Collins · Ut Southwestern Medical Center · R01 · FY2025 · AI

Drug Target Discovery, Validation, and Prioritization for Schistosomiasis

$819,288
James J Collins · Ut Southwestern Medical Center · R01 · FY2023 · AI

Drug Target Discovery, Validation, and Prioritization for Schistosomiasis

$819,288
James J Collins · Ut Southwestern Medical Center · R01 · FY2024 · AI

Molecular, Cellular, and Tissue Characterization Unit

$819,068
Joe W. Gray · Oregon Health & Science University · U2C · FY2018 · CA

Supporting Biomedical Discovery with the ROBOKOP Graph Knowledgebase.

$819,030
Alexander Tropsha · Univ Of North Carolina Chapel Hill · U24 · FY2022 · ES

New Roles of Magnesium as a Regulatory Ion in Immune Responses and Cell Behavior

$818,915
Michael J Lenardo · National Institute Of Allergy And Infectious Diseases · ZIA · FY2019 · AI

Bioinformatics Core

$818,833
Faye Schilkey · New Mexico State University Las Cruces · P20 · FY2017 · GM

Genetic Discovery and Application in a Clinical Setting Continuing a Partnership

$818,798
Eric B Larson · Kaiser Foundation Health Plan Of Washington · U01 · FY2011 · HG

The Role of Biofilms in the Pathogenesis of Otorrhea

$818,770
Garth D. Ehrlich · Allegheny-Singer Research Institute · R01 · FY2008 · DC

Safety and Efficacy of Human Clinical Trials Using Kidney-on-a-Chip Microphysiological Systems

$818,669
Jonathan Himmelfarb · University Of Washington · UG3 · FY2020 · TR

Immobilized Receptors In Drug Discovery

$818,639
Irving William Wainer · National Institute On Aging · ZIA · FY2011 · AG

Project 3: Defining and defeating the mechanisms of outer membrane biogenesis in Gram-negative bacteria

$818,532
Thomas G Bernhardt · Harvard Medical School · U19 · FY2022 · AI

Inhibitors and Probes of HIV-1 Cell Fusion

$818,419
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Discovery of Natural Products and Natural Product-Like Inhibitors

$818,419
Carole Bewley · National Institute Of Diabetes And Digestive And Kidney Diseases · ZIA · FY2015 · DK

Development of Angiotensin AT2 inhibitors for neuropathic pain relief

$818,360
Vsevolod Katritch · University Of Southern California · UG3 · FY2025 · NS

West Virginia University Injury Control Research Center

$818,358
Robert M Bossarte · West Virginia University · R49 · FY2018 · CE

Perfusable 3D human cardiac constructs for heart regeneration

$818,254
Ying Zheng · University Of Washington · R01 · FY2019 · HL

Advancing method benchmarking and data sharing through crowd-sourced competitions in cancer research

$818,213
James A Eddy · Sage Bionetworks · U24 · FY2021 · CA

NCI Program for Natural Products Discovery - Cures

$818,176
Barry Okeefe · Division Of Basic Sciences - Nci · ZIA · FY2023 · CA

The Unviersity of Michigan Injury Center

$818,045
Rebecca M. Cunningham · University Of Michigan At Ann Arbor · R49 · FY2017 · CE

The Unviersity of Michigan Injury Center

$818,045
Rebecca M. Cunningham · University Of Michigan At Ann Arbor · R49 · FY2018 · CE

Using genetic variation to study biology of blood lipids & coronary heart disease

$817,960
Cristen J Willer · University Of Michigan At Ann Arbor · R01 · FY2015 · HL

1/4-The Autism Sequencing Consortium: Autism gene discovery in >20,000 exomes

$817,786
Joseph D. Buxbaum · Icahn School Of Medicine At Mount Sinai · U01 · FY2013 · MH

Co-Abuse Cannabis and Tobacco

$817,694
Jenny L. Wiley · Research Triangle Institute · R33 · FY2020 · DA